PubMed Health⌕ Search

PubMed · 15511018

On homogeneity within critical groups.

Abstract

Since the 1960s, the methodology recommended by the International Commission on Radiological Protection (ICRP) for assessment of individual doses has developed significantly, yet the specific recommendations related to the characteristics of 'critical groups' for the purposes of protection of the public have been interpreted but are relatively unchanged. This paper examines developments relevant to the criteria for appropriate homogeneity of habits within critical groups. It is suggested that, with the need for additivity of effective doses summed over different contributing exposure pathways, an important criterion for selection of the critical group is homogeneity of summed effective doses rather than, necessarily, of the underlying factors such as ages and habits focusing on a particular pathway. This implies that there need be less emphasis than before on the term 'critical pathway'. However, examples of recent retrospective assessments near UK nuclear establishments are given and it is shown that, in practice, critical groups selected on the basis of summed effective doses are still fairly homogeneous in terms of detailed habits.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G J Hunt. 2004. On homogeneity within critical groups.. https://doi.org/10.1088/0952-4746%2F24%2F3%2F005

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

Since the publication of the Revised European-American Classification of Lymphoid Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have been generated through iterative international efforts to achieve broad consensus among hematopathologists, geneticists, molecular scientists, and clinicians. Significant progress has recently been made in the characterization of malignancies of the immune system, with many new insights provided by genomic studies. They have led to this proposal. We have followed the same process that was successfully used for the third and fourth editions of the World Health Organization Classification of Hematologic Neoplasms. The definition, recommended studies, and criteria for the diagnosis of many entities have been extensively refined. Some categories considered provisional have now been upgraded to definite entities. Terminology for some diseases has been revised to adapt nomenclature to the current knowledge of their biology, but these modifications have been restricted to well-justified situations. Major findings from recent genomic studies have impacted the conceptual framework and diagnostic criteria for many disease entities. These changes will have an impact on optimal clinical management. The conclusions of this work are summarized in this report as the proposed International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors.

Advisory Committees↗